Skip to main content

Peer Review reports

From: Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial

Original Submission
24 Oct 2018 Submitted Original manuscript
26 Nov 2018 Reviewed Reviewer Report - Mariusz Chabowski
15 Jan 2019 Reviewed Reviewer Report - Bach Duc-Hiep
10 Apr 2019 Author responded Author comments - Daniel Preto
Resubmission - Version 2
10 Apr 2019 Submitted Manuscript version 2
11 Apr 2019 Editorially accepted
25 Apr 2019 Article published 10.1186/s12885-019-5599-z

You can find further information about peer review here.

Back to article page